Capricor Therapeutics, Inc.
CAPR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133869
No open-market purchases or sales by Capricor Therapeutics, Inc. insiders were filed in the last 90 days; 169 institutions reported holding it in 13F filings for Q2 2026, worth $941.6M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Capricor Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 115 | 4 | 132 | +21 |
| Shares | 14.5M | 94.5K | 27.4M | +13.1M (+91.0%) |
| Value | $104.1M | $695.7K | $790.7M | +$687.2M (+664.6%) |
4 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (45)
Institutions that held Capricor Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (24)
Institutions that held Capricor Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Pier Capital, LLC | 496,554 | $3.58M |
| Gsa Capital Partners LLP | 215,675 | $1.55M |
| Kennedy Capital Management, Inc. | 94,420 | $680.8K |
| Two Sigma Advisers, LP | 74,200 | $535.0K |
| Jane Street Group, LLC | 68,145 | $491.3K |
| Voleon Capital Management LP | 43,147 | $311.1K |
| First Financial Bank - Trust Division | 28,089 | $202.5K |
| Krilogy Financial LLC | 25,800 | $160.5K |
| Alps Advisors Inc | 22,112 | $159.4K |
| Group One Trading, L.P. | 19,063 | $137.4K |
| Intech Investment Management LLC | 17,700 | $127.6K |
| Brevan Howard Capital Management LP | 17,045 | $122.9K |
| D. E. Shaw & Co., Inc. | 15,945 | $115.0K |
| Magnus Financial Group LLC | 15,000 | $108.2K |
| XTX Topco Ltd | 14,442 | $104.1K |
| Regal Investment Advisors LLC | 12,811 | $92.4K |
| PVG Asset Management Corp | 12,562 | $90.6K |
| Sanctuary Advisors, LLC | 12,442 | $89.7K |
| Legacy Capital Wealth Partners, LLC | 12,000 | $86.5K |
| Coastal Bridge Advisors, LLC | 10,894 | $78.5K |
| Quarry LP | 3,054 | $22.0K |
| FNY Investment Advisers, LLC | 1,600 | $11.0K |
| HighTower Advisors, LLC | 1,200 | $8.65K |
| SRS Capital Advisors, Inc. | 182 | $1.31K |
Not filed for Q4 2025 yet (4)
Institutions that held Capricor Therapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Wolverine Trading, LLC | 70,924 | $525.5K |
| Sheets Smith Investment Management | 14,862 | $107.2K |
| Point72 Asia (Singapore) Pte. Ltd. | 8,215 | $59.2K |
| Point72 (DIFC) Ltd | 516 | $3.72K |